| Application no. and date | 19722256.5 (espacenet) (Federated) (European Patent Register), 20190328 | | Patent/reg. no. and date | DK/EP 3773715, 20240508 | | Publication date | 20210217 | | Priority no. and date | US 201862650314 P, 20180330 | | EP pub. no. and date |
EP 3773715 20210217 | | Effective date | | | Applicant/owner | Eli Lilly and Company, Lilly Corporate Center
Indianapolis, IN 46285, US | | Applicant ref. no. | V475172DK00 | | Inventor | CANAVAN, James Benedict, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
FRIEDRICH, Stuart William, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
KRUEGER, Kathryn Ann, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
MILCH, Catherine, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US,
TUTTLE, Jay Lawrence, c/o ELI LILLY AND COMPANY P.O. Box 6288
Indianapolis, Indiana 46206-6288, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 39/395 (2006.01) , A61P 1/04 (2006.01) , C07K 16/24 (2006.01) | | Title | Mirikizumab i behandlingen af colitis ulcerosa | | Int. application no. | US2019024633 | | Int. publication no. | WO2019191464 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
